Missing/wrong data?
Log in to edit
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.
scientific article published on 13 February 2016
Author/s
author: Amy Jo Chien, Laura Esserman, Hope Rugo, Michelle E Melisko, Mark M Moasser, Pamela Munster, Laura J. van't Veer, Christina Yau
Work details
Publication date
February 13, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.